Image For Activity Cover
Late-Breaking Clinical Trials - Innovation Boulevard
Description
Our quest to find answers to important questions starts with the ingenuity of curious scientists presenting their work in this session. Ideas on trial at the click of a button.

Scheduled Interactive Session
Meet the Trialists: 11:00 AM EDT, Friday, May 8, 2020
To attend the scheduled sessions, please log in to Heart Rhythm 365.
Presenters

Late Breaking Clinical Trials - Innovation Boulevard

Moderator                Andrea M. Russo, MD, FHRS
                                 Cooper University Hospital, Moorestown, NJ

Commentators         David J. Callans, MD, FHRS, CCDS
                                   Hospital of the Univ of Pennsylvania, Washington Crossing, PA 

                                   Usha B. Tedrow, MD, MS, FHRS
                                   Brigham and Women`s Hospital, Boston, MA 

LBCT & Submitting Authors

Left Bundle Branch Pacing As A Novel Strategy For Cardiac Resynchronization Therapy: Results From International LBBP Collaborative Study Group.
Pugazhendhi Vijayaraman, MD, FHRS, Geisinger Heart Institute, Mountain Top, PA

Longer Term Results From A Phase I/II Study Of EP-guided Noninvasive Cardiac Radioablation For Treatment Of Ventricular Tachycardia (ENCORE-VT).
Philip Cuculich, MD, Washington University, St. Louis, MO 

Pulsed AF: First Human Experience And Acute Procedural Outcomes Using A Novel Pulsed Field Ablation System
.
Atul Verma, MD, FHRS, Southlake Regional Health Center, Toronto, ON, Canada

Point-by-point Pulsed Field Ablation (+/- Radiofrequency Ablation) To Treat Atrial Fibrillation: A First-in-human Trial.
Vivek Y. Reddy, MD, Icahn School of Medicine at Mount Sinai, New York, NY


Understanding Outcomes With The S-ICD In Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial Primary Results.
Michael R. Gold, MD, PhD, FHRS, Medical University of South Carolina, Charleston, SC 
Disclosures
A. Russo: Research (Contracted Grants for PIs and Named Investigators only) - MediLynx.               

D. Callans: Honoraria/Speaking/Consulting Fee: Biosense Webster, Boston Scientific, Biotronik, Biosense Webster, cohrex. Fellowship Support: Biosense Webster, Biotronik, Boston Scientific, Medtronic, Abbott. Board Advisory: AtriCure, Thermedical, Impulse Dynamics USA, Acutus Medical Inc.        

U. Tedrow: Honoraria/Speaking/Consulting Fee: Medtronic, Biosense Webster, St. Jude Medical, Thermedical         
                   
P. Vijayaraman: Honoraria/Speaking/Consulting Fee: Abbott, Boston Scientific, Biotronik, Medtronic, Biosense Webster. Fellowship Support: Medtronic. Research (Contracted Grants for PIs and Named Investigators only): Medtronic

P. Cuculich: Honoraria/Speaking/Consulting Fee: Medtronic, Varian Medical Systems

A. Verma:,Honoraria/Speaking/Consulting Fee: Biosense Webster, Medtronic, Thermedical. Research (Contracted Grants for PIs and Named Investigators only): Bayer Healthcare Pharmaceuticals, Biotronik

V. Reddy,: Honoraria/Speaking/Consulting Fee: Abbott, Biosense Webster, Inc., Biotronik, Boston Scientific, CardioFocus, Inc., Cardionomics, CardioNXT, EBR Systems, Impulse Dynamics USA, Medtronic, AFTX, Philips, Stimda, Thermedical Stock or Stock Options: Acutus Medical Inc, Affera Inc, Aquaheart, Autonomix, Axon, BackBeat, Biosig Technologies, Circa Scientific, Corvia Medical. EPD, EPIX Therapeutics, EpiEP, Farapulse, Medlumics, Valcare, Keystone Heart, Luxcath, NewPace Ltd, Javelin, Nuvera, VytronUS, Inc., Surecor, Middlepeak

M. Gold:  Honoraria/Speaking/Consulting Fee: EBR Systems, Boston Scientific, Abbott, Medtronic
Summary
Availability: On-Demand
Cost: FREE
Credit Offered: No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 400
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Powered By